{"product_id":"mexico-early-toxicity-testing-market-set-to-reach-usd-36-16-million-by-2030","title":"Mexico Early Toxicity Testing Market Set to Reach USD 36.16 Million by 2030","description":"\u003cp class=\"MsoNormal\"\u003eAccording to Next Move Strategy Consulting, \u003ca href=\"https:\/\/www.nextmsc.com\/report\/mexico-early-toxicity-testing-market\"\u003e\u003cstrong\u003eMexico Early Toxicity Testing Market\u003c\/strong\u003e\u003c\/a\u003e is predicted to reach USD 36.16 million with a CAGR of 16.07% till 2030.\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eThe market is driven by rise in prevalence of chronic diseases such as cancer, diabetics, and strokes in the country, which propels the need for early toxicity testing to ensure safety of new drugs and treatments. Chronic diseases, with their enduring impact on public health and well-being, have emerged as formidable challenges across Mexico.\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eHowever, stringent regulations set by regulatory bodies such as the US FDA and the EMA require extensive and rigorous testing for drug development and safety, which can be time-consuming and expensive and restrain growth of the market. \u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003eRequest For FREE Sample: \u003c\/b\u003e\u003ca href=\"https:\/\/www.nextmsc.com\/mexico-early-toxicity-testing-market\/request-sample\"\u003ehttps:\/\/www.nextmsc.com\/mexico-early-toxicity-testing-market\/request-sample\u003c\/a\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":49764521115924,"sku":"","price":1575.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0915\/3819\/4708\/files\/MexicoEarlyToxicityTestingMarket.png?v=1731730154","url":"https:\/\/nextmovestrategyconsulting.myshopify.com\/products\/mexico-early-toxicity-testing-market-set-to-reach-usd-36-16-million-by-2030","provider":"Next Move Strategy Consulting","version":"1.0","type":"link"}